Health Professionals Concerned At Further Delays To Gender Affirming Healthcare Guidelines
PATHA has been informed by Te Whatu Ora | Health New Zealand that the updated Guidelines will not be published until the Minister of Health decides on whether to introduce regulations on the ability of medical professionals to prescribe puberty blockers as part of gender affirming healthcare.
The guideline's advice on prescribing puberty blockers was updated in November 2024 to reflect the Ministry of Health's position statement on the use of these medications. This advice spans just 6 of the total 182 pages of information contained in the guidelines. The guidance is evidence-based, aligns with international best practice and guidelines, and supports a holistic approach to gender affirming medical care for young people who need it.
'Medical professionals working in this area are constantly being asked by colleagues for clinical guidance on gender-affirming healthcare,' says Dr Rona Carroll, a Specialist General Practitioner and Vice-President of PATHA. 'By not publishing the updated guidelines, the government is stopping healthcare providers from being guided by evidence-based, up-to-date New Zealand specific information. We have been given no timeframe for when to expect a decision about the puberty blocker consultation or the updated guidelines. Considering how many other areas of health these guidelines include, and that the advice on prescribing puberty blockers is in line with the Ministry's position statement, the updated guidelines should be published immediately. I think clinicians would be providing safer care if they had access to these guidelines today.'
On Wednesday, 28 May, PATHA published an open letter calling on the Minister of Health, Simeon Brown and the Associate Minister for Health, Matt Doocey, to release the updated guidance.
This letter was signed by over 500 medical bodies, clinicians and community organisations. Signatories include the Royal New Zealand College of General Practitioners, the New Zealand Society of Endocrinology, the College of Child and Youth Nurses, and the Paediatric Society of New Zealand.
The evidence-based guidelines, which have been peer reviewed by clinicians with expertise in this care from within New Zealand and internationally, provide detailed information on a wide range of topics relevant to healthcare for transgender and non-binary people. This includes several revised chapters from the 2018 edition in line with emerging medical research.
'I'm proud of the amount of work the authors have put into these guidelines, bringing their extensive collective expertise into creating guidance that is broad and has a holistic view of transgender health,' says Jennifer Shields, PATHA President. 'These guidelines cover so much more than puberty blocker medication, and this information is important for all healthcare workers to have.'
'It is clear that there is no evidence-based justification for considering restrictions on prescribing puberty blockers to transgender young people,' Shields says. 'These medications continue to be prescribed to children for other indications, and limitations in the quality of the academic evidence are not unique to this care. Healthcare professionals are now left wondering if this government is being pulled into alarming 'culture war' trends away from best practice medical care, and into anti-transgender policies that lead to a reduction in patients' rights and freedoms, and set precedent for making clinical decisions based on political beliefs rather than what's best for patients.'
'This is clear evidence of ideological interference in an operational, professional frontline medical resource that is being requested by the health sector,' Carroll said. 'We reiterate our call for the Government to allow Te Whatu Ora Health New Zealand to publish these updated guidelines immediately.'
Background information
Statement on puberty blockers
On 21st November 2024, the Ministry of Health published a position statement on the use of puberty blockers in gender affirming care, emphasising that puberty blockers could continue to be prescribed when needed as part of interdisciplinary teams. The Government expressed an intention to explore further restrictions on access to this care, and opened public consultation on possible restrictions. This consultation closed on 20th January 2025.
A memo sent to then Minister of Health Shane Reti on 30 April 2024 was released to PATHA under the Official Information Act. In this memo, the Ministry of Health clarified that:
'There is currently no evidence that individual clinicians are prescribing [puberty blockers] outside of an interprofessional team.'
This shows that concerns about individual professionals prescribing puberty blockers inappropriately are unfounded, and current prescribing practices are already in line with the Ministry's position statement.
PATHA previously published a collective statement opposing the restrictions the Government is considering on the prescription of puberty blockers to transgender young people. This statement also received broad support from medical bodies, including the New Zealand Paediatrics Society and the New Zealand Society of Endocrinology. The statement reads [in part]:
'The Ministry of Health Evidence Brief identified that any evidence of harm associated with providing puberty-blocking medication is limited and inconclusive, and withholding this care may exacerbate gender dysphoria and negatively impact mental health. Equitable and non-discriminatory access to this care should be provided and maintained throughout the country.
Decisions about prescribing puberty blockers should continue to be made collaboratively between young people, their families or support people, and the health professionals involved in their care. These decisions are individualised, based on informed consent, and guided by professional training, clinical experience, and the best available evidence. Any move to restrict access to puberty blockers would be a political decision and not one based on clinical guidance from health experts in New Zealand and international best practice. Medical decisions should remain free from political interference.'
Background on puberty blockers
Puberty blockers are a medication called gonadotrophic releasing hormone (GnRH) agonists. They were developed in the 1980s for use in much younger children with precocious (early) puberty, and have been used in gender affirming care for over 20 years. They halt the development of secondary sexual characteristics, such as breast growth or voice deepening, and can relieve distress associated with these bodily changes for transgender young people. Puberty blockers have the benefit of allowing the young person time before making any decisions regarding starting on gender affirming hormone therapy.
The effect puberty blockers have on pausing pubertal changes is reversible. Once the puberty blocker medication has been stopped, puberty will resume as it would have done without medication.
All medications have known or potential risks, but evidence and experience to date does not raise significant concerns about the safety of puberty blockers. As is the case in all medical prescribing, risks, side effects and benefits of medications are discussed with patients as part of the informed consent process before prescribing.
There are also risks to not prescribing medications when they are indicated. Puberty results in irreversible physical changes, which can result in lifelong distress and gender dysphoria for some transgender people.
In every area of healthcare, decisions about treatment and medication prescribing take all of these aspects into account, and health professionals support patients and their families to weigh up the pros and cons for their individual situation. Gender affirming healthcare is no different. Decisions about whether to start puberty blockers are made between health professionals, young people and their whānau. These are healthcare decisions which should remain free from ideological political interference.
Clinicians who initiate puberty blockers should be experienced in providing gender affirming healthcare and working within an interdisciplinary team. It is essential that access to this care and to puberty blocker medication is maintained.
Topics covered by the updated Guidelines
Advice on the prescription of puberty blockers is a small portion of the content covered by the updated guidelines. The updated guidance also includes detailed information on a broad number of other areas of transgender health, including whānau support, creating inclusive clinical environments, non-medical and non-surgical gender affirmation, speech and language therapy, fertility and sexual health, mental wellbeing, gender-affirming hormone therapy, and detransition, as well as specific guidance for Māori, Pasifika, and refugee and asylum seeker trans people.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
RNZ News
a day ago
- RNZ News
Bonuses promised for doctors in short-staffed areas, union says existing allowances aren't being paid
Photo: RNZ Health NZ is promising bonus payments to senior doctors who work in hard-to-staff areas, although the union is accusing it of failing to consistently pay allowances now. The Association of Salaried Medical Specialists, which represents 5500 senior hospital doctors and dentists, has criticised Te Whatu Ora's new offer to its members as amounting to "an effective pay cut" for 90 percent of them. Union head Sarah Dalton was also sceptical of Health NZ's proposal to ring-fence $32 million over two years for an incentive to doctors to work in areas or specialities with particular shortages . The agency was already paying $384m a year on contingency staffing which was "driving people out of salaried into locum work and temporary gigs", and current systems for paying allowances were ad hoc and "shambolic", she said. However, Health NZ's industrial relations lead, Robyn Shearer, said incentive funding showed the agency was listening to what the union had to say about the need to retain staff in those areas. Specific details on how to allocate that money were yet to be agreed, she said. "We need to get round the table and work ... through that in the bargaining process. "Our intention is to work on that together with the union, so we are keen as part of proposed settlement to have it in agreement." Association of Salaried Medical Specialists's Sarah Dalton. Photo: RNZ / Jimmy Ellingham Shearer agreed there was work to do on consistently applying allowances that had already been agreed, including the extra ED allowance that came out of the previous bargaining round. "We are definitely keen to work on better consistency - there's a big piece of work around application of allowances up and down the country, and we're keen to work with the union on that." Health NZ would "much rather" employ permanent staff than have to find locums, she said. "But there are good reasons for employing locums, including covering staff sickness and unfilled posts. They have an important role to play while we seek permanent long-term solutions." Health NZ's industrial relations lead, Robyn Shearer. Photo: RNZ Insight/Karen Brown Should Health NZ's offer be accepted, first-year specialists would get an extra $17,000 in their pay packets over the 21-month term, and second year specialists more than $11,000. "Senior doctors at the top of the pay scale would receive an increase to base pay of more than $9000 to more than $277,000 over the course of the proposed settlement. We think that's a very fair pay offer." Sign up for Ngā Pitopito Kōrero , a daily newsletter curated by our editors and delivered straight to your inbox every weekday.
Otago Daily Times
a day ago
- Otago Daily Times
Staff 'responded immediately' to patient escape
By Sam Sherwood of RNZ Mental Health Minister Matt Doocey has reiterated to Health New Zealand that patient and public safety are of "paramount importance", after a man absconded from a mental health facility. Canterbury police released a statement about 9pm on Thursday appealing for information about the 35-year-old who had absconded from the care of another agency. Police had been notified about 6pm that the man was missing. They said he was dangerous and shouldn't be approached. The man was found about 10pm. RNZ understands the man absconded from Hillmorton Hospital. He was found about 6km away from the mental health facility. Health New Zealand has been approached for comment. A spokesperson for Mental Health Minister Matt Doocey told RNZ his office was advised on Thursday night about a patient leaving Hillmorton. "The Minister was advised by Health New Zealand that safety of the individual and community was at the forefront in how they responded with police." HNZ staff "responded immediately" and worked with Police to safely locate the person and return them to Hillmorton last night. "Health New Zealand is taking the incident seriously and there will be a rapid review and will take appropriate action as required. "The Minister reiterated to HNZ that patient and public safety are of paramount importance, and Health New Zealand have assured the Minister that they are taking all the necessary steps to ensure both." The incident comes three years after Hillmorton forensic mental health patient Zakariye Mohamed Hussein murdered Laisa Waka Tunidau as she walked home from work. Hussein was on community leave at the time of the killing. Two reviews were ordered, one into Hussein's care, and another looking at Canterbury District Mental Health Services. In June another Hillmorton mental health patient, Elliot Cameron was sentenced in the High Court at Christchurch to life imprisonment with a minimum term of 10 years for murdering 83-year-old Frances Anne Phelps, known as Faye in October last year. Following his sentencing a suppression order was lifted allowing RNZ to report Cameron killed his brother Jeffrey Cameron in 1975. A jury found him not guilty of murder by reason of insanity and he was detained as a special patient. Cameron was made a voluntary patient at Hillmorton Hospital in 2016, and then in October last year murdered Phelps, striking her with an axe. RNZ exclusively obtained emails from Cameron to his cousin Alan Cameron sent over more than a decade, detailing his concerns that he might kill again. In response to the revelations, Chief Victims Advisor Ruth Money said it was hard to see Phelps' death as "anything other than preventable". RNZ earlier revealed another case involving a man who was made a special patient under the Mental Health Act after his first killing was recently found not guilty of murder by reason of insanity for a second time, after killing someone he believed was possessed. After that article, Money called for a Royal Commission of Inquiry into forensic mental health facilities. After Cameron's first killing was revealed, Money said she stood by her recommendation. "The public deserves an inquiry that can give actionable expert recommendations, as opposed to multiple coroners' inquests and recommendations that do not have the same binding influence. The patients themselves, and the public will be best served by an independent inquiry, not another internal review that changes nothing."
Otago Daily Times
a day ago
- Otago Daily Times
Shuffles continue at top of hospital project
A fast-rising bureaucrat brought in to helm the government's reset of the new Dunedin hospital project has been dumped from the inpatient build, the Otago Daily Times understands. Health New Zealand Te Whatu Ora (HNZ) head of infrastructure delivery Blake Lepper had fronted the $1.88 billion Dunedin hospital project for HNZ, including standing alongside ministers at press briefings and being described as ''senior responsible officer''. Mr Lepper arrived at HNZ last March from a management role at the Infrastructure Commission, but after repeated questions to HNZ from the Otago Daily Times about whether Mr Lepper was still senior responsible officer for the inpatient build, the agency admitted he is not. Tony Lloyd, who was removed as the build's programme director in November, has been confirmed as project director for the build. HNZ said Mr Lepper, who has a law and physics degree from the University of Otago, retained responsibilities for completion of Dunedin's outpatient building, and workforce and data and digital work streams, as well as other infrastructure projects. The period of Mr Lepper's leadership of the inpatient build was fraught. After piles were driven, no contract was awarded to build the inpatients building and ministers claimed a project blowout, and sought a reset. Meanwhile, sources moaned about HNZ leadership prevarication causing delays. The option of refurbishing the existing ward block, rather than constructing a new inpatient building, had been previously considered and ditched, but was reconsidered under Mr Lepper and dismissed again. Mr Lepper's departure from the inpatient building comes hot on the heels of other senior personnel changes and announcements relating to how the project is staffed, delivered and governed. Last month, corporate boss Evan Davies — group chief executive of gas and property company Todd and member of a new HNZ health infrastructure committee — was appointed as crown manager of the inpatient building project by Health Minister Simeon Brown. When announcing the appointment, Mr Brown said HNZ had ''struggled to maintain momentum on the project and identify a path forward''. Mr Brown, who had spoken in January alongside Mr Lepper at a press conference announcing the inpatient build would go ahead, has repeatedly stressed that Mr Davies now has authority to make appointments to run the project. In the press conference, Mr Brown said the focus was ''cracking on'' with the build. Mr Lepper's messaging in the conference was less clear. He said HNZ was committed to leading the project, but was also ''looking across government to get the support we need to make sure we can move''. He was ''really grateful'' for support that was being provided by Crown Infrastructure Delivery (CID), a crown agency tasked with helping government departments manage infrastructure builds. Subsequent to Mr Davies becoming crown manager, HNZ sent Australian construction giant CPB a ''letter of intent'' to hire the firm to deliver the inpatient building. CID, which has no hospital-building experience, will not be project managing CPB's work. A question mark also hovers over the future and role of the project's governance committee, the Project Steering Group (PSG), which is meant to oversee the build. Rebecca Wark, the former head of health construction for New South Wales, was the most recent independent chairwoman of the PSG, but HNZ said her contract ended last month and it was ''currently reviewing the structure of the group''.
